Infection of Eye Due to Pseudomonas Aeruginosa Treated With Polymyxin B and ``Varidase''

Experimental Pseudomonas Keratitis

“…Prior to 1950, however, the degree of virulence of the organism was probably more responsible for the ultimate outcome of the corneal disease than any particular form of therapy. [84][85][86][87][88][89][90][91] The management of Pseudomonas keratitis began to change around 1952 when reports of clinically significant therapeutic success labeled polymyxin B sulfate the drug of choice.67, [92][93][94] Colistin (polymyxin E) also proved effective in England,95 and became another sound therapeutic choice in the United States in the 1960s.96-100…”

Experimental Pseudomonas Keratitis

“…Prior to 1950, however, the degree of virulence of the organism was probably more responsible for the ultimate outcome of the corneal disease than any particular form of therapy. [84][85][86][87][88][89][90][91] The management of Pseudomonas keratitis began to change around 1952 when reports of clinically significant therapeutic success labeled polymyxin B sulfate the drug of choice.67, [92][93][94] Colistin (polymyxin E) also proved effective in England,95 and became another sound therapeutic choice in the United States in the 1960s.96-100…”

Experimental Pseudomonas Keratitis

“…Prior to 1950, however, the degree of virulence of the organism was probably more responsible for the ultimate outcome of the corneal disease than any particular form of therapy. [84][85][86][87][88][89][90][91] The management of Pseudomonas keratitis began to change around 1952 when reports of clinically significant therapeutic success labeled polymyxin B sulfate the drug of choice.67, [92][93][94] Colistin (polymyxin E) also proved effective in England,95 and became another sound therapeutic choice in the United States in the 1960s.96-100…”

Experimental Pseudomonas Keratitis

“…Prior to 1950, however, the degree of virulence of the organism was probably more responsible for the ultimate outcome of the corneal disease than any particular form of therapy. [84][85][86][87][88][89][90][91] The management of Pseudomonas keratitis began to change around 1952 when reports of clinically significant therapeutic success labeled polymyxin B sulfate the drug of choice.67, [92][93][94] Colistin (polymyxin E) also proved effective in England,95 and became another sound therapeutic choice in the United States in the 1960s.96-100…”